Articles published by Biora Therapeutics, Inc.
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
November 13, 2023
Via GlobeNewswire
Tickers
BIOR
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics to Report Third Quarter 2023 Financial Results and Provide Corporate Update
November 06, 2023
Via GlobeNewswire
Tickers
BIOR
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics Submits Updated IND Application for BT-600
October 30, 2023
Via GlobeNewswire
Tickers
BIOR
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics to Submit Updated IND Application for BT-600
October 23, 2023
Via GlobeNewswire
Tickers
BIOR
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics Announces Submission of IND Application to the U.S. FDA for BT-600 Program
September 25, 2023
Via GlobeNewswire
Tickers
BIOR
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics Reduces Debt and Largest Shareholder Increases Equity Exposure
September 19, 2023
Via GlobeNewswire
Tickers
BIOR
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference
September 11, 2023
Via GlobeNewswire
Tickers
BIOR
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics Progresses its BioJet™ Systemic Oral Delivery Platform
September 05, 2023
Via GlobeNewswire
Tickers
BIOR
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
August 14, 2023
Via GlobeNewswire
Tickers
BIOR
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics Announces New Patents Covering its BioJet™ Systemic Oral Delivery Platform
August 03, 2023
Via GlobeNewswire
Tickers
BIOR
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics to Participate in Canaccord Genuity 43rd Annual Growth Conference
August 02, 2023
Via GlobeNewswire
Tickers
BIOR
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics to Report Second Quarter 2023 Financial Results and Provide Corporate Update
July 17, 2023
Via GlobeNewswire
Tickers
BIOR
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Via GlobeNewswire
Tickers
BIOR
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics Announces New Patents for its NaviCap™ Targeted Oral Delivery Platform
June 28, 2023
Via GlobeNewswire
Tickers
BIOR
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Via GlobeNewswire
Tickers
BIOR
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics to Participate in Crohn’s & Colitis Foundation’s IBD Innovate Conference
April 20, 2023
Via GlobeNewswire
Tickers
BIOR
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics Announces Bioavailability Results for Oral Delivery of GLP-1 Receptor Agonist
February 23, 2023
Via GlobeNewswire
Tickers
BIOR
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics Announces Improved Bioavailability Results for its Systemic Delivery Platform
February 16, 2023
Via GlobeNewswire
Tickers
BIOR
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics Receives Pre-IND Feedback from FDA and Provides Update on Key Programs for 2023
January 09, 2023
Via GlobeNewswire
Tickers
BIOR
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.